Filing Details
- Accession Number:
- 0000920465-17-000037
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-06 16:02:20
- Reporting Period:
- 2017-03-02
- Filing Date:
- 2017-03-06
- Accepted Time:
- 2017-03-06 16:02:20
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
920465 | La Jolla Pharmaceutical Co | LJPC | Biological Products, (No Disgnostic Substances) (2836) | 330361285 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1287235 | F George Tidmarsh | C/O La Jolla Pharmaceutical Company, 10182 Telesis Court, 6Th Floor San Diego CA 92121 | President, Ceo & Secretary | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-03-02 | 2,000 | $34.18 | 1,353,086 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-03-03 | 1,000 | $34.15 | 1,354,086 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |